Hongfei Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hongfei Ge has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Jun Zhong
Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital Third Military Medical University (Army Medical University) Chongqing China
9 shared publicationsQuan Hu
Department of Emergency, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China
9 shared publicationsChao Zhang
Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital, Third Military Medical University (Army Medical University), 400038 Chongqing, China
8 shared publications- Anyong Yu
Department of Emergency, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China.
7 shared publications Ji Zhang
Department of Emergency, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China
7 shared publicationsShuhong Wang
Department of Emergency Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China zmchospital.com.cn
7 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Stem Cells International
- Vol. 2026 (1)
Mechanisms of Neural Stem Cell Mediated Neurogenesis and Therapeutic Prospects Following Ischemic Stroke: A Review
Ischemic stroke is a refractory cerebrovascular disorder characterized by high incidence, disability, and mortality rates. Its core pathological features include extensive neuronal death within the ischemic zone and irreversible damage to neural circuits. Given the limited regenerative capacity of the central nervous system, regulating endogenous neurogenesis and reconstructing functional circuits are important strategies for treating neurological deficits. This narrative review summarizes the dynamic processes of activation, proliferation, migration, and differentiation of endogenous neural stem cells (NSCs) following ischemic stroke, and explores the therapeutic potential of exogenous NSC transplantation and its current applications. Distinct from existing reviews, this work systematically integrates neuroimmune crosstalk, metabolic reprogramming, and meningeal‑choroid‑plexus‑mediated niche regulation, further proposing a staged multimodal precision intervention framework. We also highlight critical confounding factors, including aging‑driven regenerative decline, and explicitly separate preclinical animal findings from limited human clinical evidence. Meanwhile, this review elucidates the core mechanisms through which neurogenesis mediates tissue repair and functional recovery in ischemic brain tissue. Furthermore, this review refines future research directions, such as spatiotemporally specific precision interventions and multimodal combination therapies, providing a systematic theoretical basis and research framework for developing novel NSC‐based therapeutic strategies for ischemic stroke.
- 1 January 2026
- Published by Wiley in Stem Cells International
- Vol. 2026 (1)
Open AccessMechanisms of Neural Stem Cell Mediated Neurogenesis and Therapeutic Prospects Following Ischemic Stroke: A Review
Ischemic stroke is a refractory cerebrovascular disorder characterized by high incidence, disability, and mortality rates. Its core pathological features include extensive neuronal death within the ischemic zone and irreversible damage to neural circuits. Given the limited regenerative capacity of the central nervous system, regulating endogenous neurogenesis and reconstructing functional circuits are important strategies for treating neurological deficits. This narrative review summarizes the dynamic processes of activation, proliferation, migration, and differentiation of endogenous neural stem cells (NSCs) following ischemic stroke, and explores the therapeutic potential of exogenous NSC transplantation and its current applications. Distinct from existing reviews, this work systematically integrates neuroimmune crosstalk, metabolic reprogramming, and meningeal‑choroid‑plexus‑mediated niche regulation, further proposing a staged multimodal precision intervention framework. We also highlight critical confounding factors, including aging‑driven regenerative decline, and explicitly separate preclinical animal findings from limited human clinical evidence. Meanwhile, this review elucidates the core mechanisms through which neurogenesis mediates tissue repair and functional recovery in ischemic brain tissue. Furthermore, this review refines future research directions, such as spatiotemporally specific precision interventions and multimodal combination therapies, providing a systematic theoretical basis and research framework for developing novel NSC‐based therapeutic strategies for ischemic stroke.
- Open Access
- 1 August 2025
- Published by Wiley in Cell Proliferation
- Vol. 59 (2) , e70093
Dysregulation of Rho‐Associated Coiled‐Coil Protein Kinase1 Depletes Neural Stem Cell Pool and Impairs Hippocampal Neurogenesis After Traumatic Brain Injury
Traumatic brain injury (TBI) represents a global health burden, often resulting in persistent neurological deficits due to impaired hippocampal neurogenesis. Nevertheless, the temporal progression of post‐TBI neurogenesis and its molecular mechanisms remain elusive. To investigate the mechanism of impaired hippocampal neurogenesis and neurological deficits following TBI. Single‐cell RNA sequencing (scRNA‐seq) was employed to explore the mechanism of abnormal hippocampal neurogenesis after TBI in mice. Antagonists and conditional gene knockout (CKO) strategies were applied to dissect the molecular function of target genes. Here, we found that neural stem cells (NSCs) were hyperactivated as observed in Nestin‐GFP reporter mice in hippocampus during the early phases of TBI, followed by progressive depletion of the NSC pool, impaired neurogenesis, and the onset of progressive cognitive dysfunction. ScRNA‐seq transcriptomic analysis revealed sustained upregulation of Rho‐associated coiled‐coil protein kinase 1 (ROCK1) in hippocampal NSCs post‐TBI. Pharmacological inhibition of ROCK1 or ROCK1 CKO rescued chronic neurogenic deficits and improved cognitive functions in TBI mice. Mechanistically, ROCK1 dysregulation impaired neurogenesis via aberrant AKT hyperphosphorylation, establishing a unidirectional ROCK1‐AKT signalling axis in adult hippocampal neurogenesis. Our findings position ROCK1 as a pivotal regulator of the post‐TBI NSC pool hyperactivation and aberrant neurogenesis and propose targeted kinase inhibition strategies as a potential therapy to mitigate abnormal neurogenesis in TBI patients.
- 1 August 2025
- Published by Wiley in Cell Proliferation
- Vol. 59 (2) , e70093
Open AccessDysregulation of Rho‐Associated Coiled‐Coil Protein Kinase1 Depletes Neural Stem Cell Pool and Impairs Hippocampal Neurogenesis After Traumatic Brain Injury
Traumatic brain injury (TBI) represents a global health burden, often resulting in persistent neurological deficits due to impaired hippocampal neurogenesis. Nevertheless, the temporal progression of post‐TBI neurogenesis and its molecular mechanisms remain elusive. To investigate the mechanism of impaired hippocampal neurogenesis and neurological deficits following TBI. Single‐cell RNA sequencing (scRNA‐seq) was employed to explore the mechanism of abnormal hippocampal neurogenesis after TBI in mice. Antagonists and conditional gene knockout (CKO) strategies were applied to dissect the molecular function of target genes. Here, we found that neural stem cells (NSCs) were hyperactivated as observed in Nestin‐GFP reporter mice in hippocampus during the early phases of TBI, followed by progressive depletion of the NSC pool, impaired neurogenesis, and the onset of progressive cognitive dysfunction. ScRNA‐seq transcriptomic analysis revealed sustained upregulation of Rho‐associated coiled‐coil protein kinase 1 (ROCK1) in hippocampal NSCs post‐TBI. Pharmacological inhibition of ROCK1 or ROCK1 CKO rescued chronic neurogenic deficits and improved cognitive functions in TBI mice. Mechanistically, ROCK1 dysregulation impaired neurogenesis via aberrant AKT hyperphosphorylation, establishing a unidirectional ROCK1‐AKT signalling axis in adult hippocampal neurogenesis. Our findings position ROCK1 as a pivotal regulator of the post‐TBI NSC pool hyperactivation and aberrant neurogenesis and propose targeted kinase inhibition strategies as a potential therapy to mitigate abnormal neurogenesis in TBI patients.
- Open Access
- 12 April 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (6) , 108315
Activation of GPER1 alleviates white matter injury by promoting microglia M2 polarization through EGFR/Stat3 pathway in intracerebral hemorrhage mice
- 12 April 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (6) , 108315
Open AccessActivation of GPER1 alleviates white matter injury by promoting microglia M2 polarization through EGFR/Stat3 pathway in intracerebral hemorrhage mice
- Open Access
- 19 April 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (8) , 4804-4809
Clot removAl with or without decompRessive craniectomy under ICP monitoring for supratentorial IntraCerebral Hemorrhage (CARICH): a randomized controlled trial
Background: Decompressive craniectomy (DC), a surgery to remove part of the skull and open the dura mater, maybe an effective treatment for controlling intracranial hypertension. It remains great interest to elucidate whether DC is beneficial to intracerebral hemorrhage (ICH) patients who warrant clot removal (CR) to prevent intracranial hypertension. Methods: The trial was a prospective, pragmatic, controlled trial involving adult patients with ICH who were undergoing removal of hematoma. ICH patients were randomly assigned at a 1:1 ratioto undergo CR with or without DC under the monitoring of intracranial pressure. The primary outcome was the proportion of unfavorable functional outcome (modified Rankin Scale 3–6) at 3 months. Secondary outcomes included the mortality at 3 months and the occurrence of reoperation. Results: A total of 102 patients were assigned to the CR with DC group and 102 to the CR group. Median hematoma volume was 54.0 ml (range 30–80 ml) and median preoperative Glasgow Coma Scale was 10 (range 5–15). At 3 months, 94 patients (92.2%) in CR with DC group and 83 patients (81.4%) in the CR group had unfavorable functional outcome (P=0.023). Fourteen patients (13.7%) in the CR with DC group died versus five patients (4.9%) in the CR group (P=0.030). The number of patients with reoperation was similar between the CR with DC group and CR group (5.9 vs. 3.9%; P=0.517). Postoperative intracranial pressure values were not significantly different between two groups and the mean values were less than 20 mmHg. Conclusions: CR without DC decreased the rate of modified Rankin Scale score of 3–6 and mortality in patients with ICH, compared with CR with DC.
- 19 April 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (8) , 4804-4809
Open AccessClot removAl with or without decompRessive craniectomy under ICP monitoring for supratentorial IntraCerebral Hemorrhage (CARICH): a randomized controlled trial
Background: Decompressive craniectomy (DC), a surgery to remove part of the skull and open the dura mater, maybe an effective treatment for controlling intracranial hypertension. It remains great interest to elucidate whether DC is beneficial to intracerebral hemorrhage (ICH) patients who warrant clot removal (CR) to prevent intracranial hypertension. Methods: The trial was a prospective, pragmatic, controlled trial involving adult patients with ICH who were undergoing removal of hematoma. ICH patients were randomly assigned at a 1:1 ratioto undergo CR with or without DC under the monitoring of intracranial pressure. The primary outcome was the proportion of unfavorable functional outcome (modified Rankin Scale 3–6) at 3 months. Secondary outcomes included the mortality at 3 months and the occurrence of reoperation. Results: A total of 102 patients were assigned to the CR with DC group and 102 to the CR group. Median hematoma volume was 54.0 ml (range 30–80 ml) and median preoperative Glasgow Coma Scale was 10 (range 5–15). At 3 months, 94 patients (92.2%) in CR with DC group and 83 patients (81.4%) in the CR group had unfavorable functional outcome (P=0.023). Fourteen patients (13.7%) in the CR with DC group died versus five patients (4.9%) in the CR group (P=0.030). The number of patients with reoperation was similar between the CR with DC group and CR group (5.9 vs. 3.9%; P=0.517). Postoperative intracranial pressure values were not significantly different between two groups and the mean values were less than 20 mmHg. Conclusions: CR without DC decreased the rate of modified Rankin Scale score of 3–6 and mortality in patients with ICH, compared with CR with DC.
- Open Access
- 5 December 2023
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 22 (6) , 171
Kv1.3 Blockade Alleviates White Matter Injury through Reshaping M1/M2 Phenotypes via the NF-κB Signaling Pathway after Intracerebral Hemorrhage
Background: White matter injury (WMI) in basal ganglia usually induces long-term disability post intracerebral hemorrhage (ICH). Kv1.3 is an ion channel expressed in microglia and induces neuroinflammation after ICH. Here, we investigated the functions and roles of Kv1.3 activation-induced inflammatory response in WMI and the Kv1.3 blockade effect on microglia polarization after ICH. Methods: Mice ICH model was constructed by autologous blood injection. The expression of Kv1.3 was measured using immunoblot, real-time quantitative polymerase chain reaction (RT-qPCR), and immunostaining assays. Then, the effect of administration of 5-(4-Phenoxybutoxy) psoralen (PAP-1), a selectively pharmacological Kv1.3 blocker, was investigated using open field test (OFT) and basso mouse score (BMS). RT-qPCR, immunoblot, and enzyme-linked immunosorbent assay (ELISA) were taken to elucidate the expression of pro-inflammatory or anti-inflammatory factors around hematoma. PAP-1’s function in regulating microglia polarization was investigated using immunoblot, RT-qPCR, and immunostaining assays. The downstream PAP-1 signaling pathway was determined by RT-qPCR and immunoblot. Results: Kv1.3 expression was increased in microglia around the hematoma significantly after ICH. PAP-1 markedly improved neurological outcomes and the WMI by reducing pro-inflammatory cytokine accumulation and upregulating anti-inflammatory factors. Mechanistically, PAP-1 reduces NF-κB p65 and p50 activation, thus facilitating microglia polarization into M2-like microglia, which exerts this beneficial effect. Conclusions: PAP-1 reduced pro-inflammatory cytokines accumulation and increased anti-inflammatory factors by facilitating M2-like microglia polarization via the NF-κB signaling pathway. Thus, the current study shows that the Kv1.3 blockade is capable of ameliorating WMI by facilitating M2-like phenotype microglia polarization after ICH.
- 5 December 2023
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 22 (6) , 171
Open AccessKv1.3 Blockade Alleviates White Matter Injury through Reshaping M1/M2 Phenotypes via the NF-κB Signaling Pathway after Intracerebral Hemorrhage
Background: White matter injury (WMI) in basal ganglia usually induces long-term disability post intracerebral hemorrhage (ICH). Kv1.3 is an ion channel expressed in microglia and induces neuroinflammation after ICH. Here, we investigated the functions and roles of Kv1.3 activation-induced inflammatory response in WMI and the Kv1.3 blockade effect on microglia polarization after ICH. Methods: Mice ICH model was constructed by autologous blood injection. The expression of Kv1.3 was measured using immunoblot, real-time quantitative polymerase chain reaction (RT-qPCR), and immunostaining assays. Then, the effect of administration of 5-(4-Phenoxybutoxy) psoralen (PAP-1), a selectively pharmacological Kv1.3 blocker, was investigated using open field test (OFT) and basso mouse score (BMS). RT-qPCR, immunoblot, and enzyme-linked immunosorbent assay (ELISA) were taken to elucidate the expression of pro-inflammatory or anti-inflammatory factors around hematoma. PAP-1’s function in regulating microglia polarization was investigated using immunoblot, RT-qPCR, and immunostaining assays. The downstream PAP-1 signaling pathway was determined by RT-qPCR and immunoblot. Results: Kv1.3 expression was increased in microglia around the hematoma significantly after ICH. PAP-1 markedly improved neurological outcomes and the WMI by reducing pro-inflammatory cytokine accumulation and upregulating anti-inflammatory factors. Mechanistically, PAP-1 reduces NF-κB p65 and p50 activation, thus facilitating microglia polarization into M2-like microglia, which exerts this beneficial effect. Conclusions: PAP-1 reduced pro-inflammatory cytokines accumulation and increased anti-inflammatory factors by facilitating M2-like microglia polarization via the NF-κB signaling pathway. Thus, the current study shows that the Kv1.3 blockade is capable of ameliorating WMI by facilitating M2-like phenotype microglia polarization after ICH.
- 11 September 2023
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (2) , 1157-1174
Targeting Ferroptosis Promotes Functional Recovery by Mitigating White Matter Injury Following Acute Carbon Monoxide Poisoning
Survivors experiencing acute carbon monoxide poisoning (ACMP) tend to develop white matter injury (WMI). The mechanism of ACMP-induced WMI remains unclear. Considering the role of ferroptosis in initiating oligodendrocyte damage to deteriorate WMI, exploring therapeutic options to attenuate ferroptosis is a feasible approach to alleviating WMI. Our results indicated that ACMP induced accumulation of iron and reactive oxygen species (ROS) eventually leading to WMI and motor impairment after ACMP. Furthermore, ferrostatin-1 reduced iron and ROS deposition to alleviate ferroptosis, thereafter reducing WMI to promote the recovery of motor function. The nuclear factor erythroid-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway was found to be involved in alleviating ferroptosis as seen with the administration of ferrostatin-1. The present study rationalizes that targeting ferroptosis to alleviate WMI is a feasible therapeutic strategy for managing ACMP.
- 11 September 2023
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (2) , 1157-1174
Targeting Ferroptosis Promotes Functional Recovery by Mitigating White Matter Injury Following Acute Carbon Monoxide Poisoning
Survivors experiencing acute carbon monoxide poisoning (ACMP) tend to develop white matter injury (WMI). The mechanism of ACMP-induced WMI remains unclear. Considering the role of ferroptosis in initiating oligodendrocyte damage to deteriorate WMI, exploring therapeutic options to attenuate ferroptosis is a feasible approach to alleviating WMI. Our results indicated that ACMP induced accumulation of iron and reactive oxygen species (ROS) eventually leading to WMI and motor impairment after ACMP. Furthermore, ferrostatin-1 reduced iron and ROS deposition to alleviate ferroptosis, thereafter reducing WMI to promote the recovery of motor function. The nuclear factor erythroid-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway was found to be involved in alleviating ferroptosis as seen with the administration of ferrostatin-1. The present study rationalizes that targeting ferroptosis to alleviate WMI is a feasible therapeutic strategy for managing ACMP.
- Open Access
- 2 June 2023
- Published by Springer Nature in Research Square
Targeting Ferroptosis Promotes Functional Recovery by Mitigating White Matter Injury Following Acute Carbon Monoxide Poisoning
Survivors experiencing acute carbon monoxide poisoning (ACMP) tend to develop white matter injury (WMI). The mechanism of ACMP-induced WMI remains unclear. Considering the role of ferroptosis in initiating oligodendrocyte damage to deteriorate WMI, exploring therapeutic options to attenuate ferroptosis is a feasible approach to managing WMI. Our results indicated that ACMP induced accumulation of iron and reactive oxygen species (ROS) eventually leading to WMI and motor impairment after ACMP. Further, ferrostatin-1 reduced iron and ROS deposition to alleviate ferroptosis, thereafter reducing WMI to promote the recovery of motor function. The nuclear factor erythroid-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway was found to be involved in alleviating ferroptosis as seen with the administration of ferrostatin-1. The present study rationalizes that targeting ferroptosis to alleviate WMI is a feasible therapeutic strategy for managing ACMP.
- 2 June 2023
- Published by Springer Nature in Research Square
Open AccessTargeting Ferroptosis Promotes Functional Recovery by Mitigating White Matter Injury Following Acute Carbon Monoxide Poisoning
Survivors experiencing acute carbon monoxide poisoning (ACMP) tend to develop white matter injury (WMI). The mechanism of ACMP-induced WMI remains unclear. Considering the role of ferroptosis in initiating oligodendrocyte damage to deteriorate WMI, exploring therapeutic options to attenuate ferroptosis is a feasible approach to managing WMI. Our results indicated that ACMP induced accumulation of iron and reactive oxygen species (ROS) eventually leading to WMI and motor impairment after ACMP. Further, ferrostatin-1 reduced iron and ROS deposition to alleviate ferroptosis, thereafter reducing WMI to promote the recovery of motor function. The nuclear factor erythroid-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway was found to be involved in alleviating ferroptosis as seen with the administration of ferrostatin-1. The present study rationalizes that targeting ferroptosis to alleviate WMI is a feasible therapeutic strategy for managing ACMP.
- Open Access
- 10 March 2023
- Published by Springer Nature in Research Square
Targeting Ferroptosis Promotes Functional Recovery Through Mitigating White Matter Injury Following Acute Carbon Monoxide Poisoning
Survivors suffering from acute carbon monoxide poisoning (ACMP) are apt to develop white matter injury (WMI). While, the mechanism that ACMP evokes WMI remains unclear. Given that ferroptosis plays an evident role in igniting oligodendrocyte damage to deteriorate WMI, exploring regimens to attenuate ferroptosis is a feasible approach to alleviate WMI post-ACMP. Here, the results indicated that ACMP induced WMI to evoke motor impairment resulting from the surplus iron and reactive oxygen species (ROS) accumulation after ACMP. And, the administration of ferrostatin-1 reduced iron and ROS deposition to repress ferroptosis, thereafter reducing WMI to promote motor recovery. Furthermore, the result demonstrated that the nuclear factor erythroid-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway was involved in attenuating ferroptosis resulting from the application of ferrostatin-1. The present study offers a rationale that targeting ferroptosis to alleviate WMI is a feasible therapeutic strategy for ACMP.
- 10 March 2023
- Published by Springer Nature in Research Square
Open AccessTargeting Ferroptosis Promotes Functional Recovery Through Mitigating White Matter Injury Following Acute Carbon Monoxide Poisoning
Survivors suffering from acute carbon monoxide poisoning (ACMP) are apt to develop white matter injury (WMI). While, the mechanism that ACMP evokes WMI remains unclear. Given that ferroptosis plays an evident role in igniting oligodendrocyte damage to deteriorate WMI, exploring regimens to attenuate ferroptosis is a feasible approach to alleviate WMI post-ACMP. Here, the results indicated that ACMP induced WMI to evoke motor impairment resulting from the surplus iron and reactive oxygen species (ROS) accumulation after ACMP. And, the administration of ferrostatin-1 reduced iron and ROS deposition to repress ferroptosis, thereafter reducing WMI to promote motor recovery. Furthermore, the result demonstrated that the nuclear factor erythroid-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway was involved in attenuating ferroptosis resulting from the application of ferrostatin-1. The present study offers a rationale that targeting ferroptosis to alleviate WMI is a feasible therapeutic strategy for ACMP.
- Open Access
- 28 November 2022
- Published by Springer Nature in Research Square
Kv1.3 blockade alleviates white matter injury through reshaping M1/M2 phenotypes after intracerebral hemorrhage
Background: White matter injury (WMI) in basal ganglia usually induces long-term disability after intracerebral hemorrhage (ICH). Kv1.3 is highly expressed in microglia, and exaggerates neuroinflammation in neurodegenerative diseases. The present study investigated the role of inflammatory response resulting from Kv1.3 activation in WMI, as well as the effect of Kv1.3 blockade on microglia polarization after ICH. Methods: ICH was introduced in mice using autologous blood. The expression of Kv1.3 was determined using real-time quantitative polymerase chain reaction (RT-qPCR), immunoblot and immunostaining assays. Then, the effect of administration of 5-(4-Phenoxybutoxy) psoralen (PAP-1), a selectively pharmacological inhibitor of Kv1.3, on functional recovery was investigated using open field test (OFT) and basso mouse score (BMS). Next, the RT-qPCR, immunoblot and enzyme linked immunosorbent assay (ELISA) assays were performed to elucidate the changes of pro-inflammatory and anti-inflammatory factors around hematoma with PAP-1 application after ICH. Thereafter, the role of PAP-1 in regulating microglia polarization was examined through RT-qPCR, immunoblot and immunostaining assays. Results: After ICH, the expression of Kv1.3 was significantly increased in microglia around hematoma after ICH. The administration of PAP-1 markedly improved neurological outcomes through reducing the accumulation of pro-inflammatory cytokines and upregulating the deposition of anti-inflammatory and neurotrophic factors. The reason for this beneficial effect ascribes to facilitating microglia polarization into M2-like microglia. Conclusion: Kv1.3 blockade using PAP-1 obviously reduced the accumulation of pro-inflammatory cytokines and upregulated the deposition of anti-inflammatory and neurotrophic factors through facilitating microglia polarization into M2-like microglia. The present study provides evidence Kv1.3 blockade is suitable to mitigate WMI through facilitating microglia transformation into M2-like phenotype after ICH.
- 28 November 2022
- Published by Springer Nature in Research Square
Open AccessKv1.3 blockade alleviates white matter injury through reshaping M1/M2 phenotypes after intracerebral hemorrhage
Background: White matter injury (WMI) in basal ganglia usually induces long-term disability after intracerebral hemorrhage (ICH). Kv1.3 is highly expressed in microglia, and exaggerates neuroinflammation in neurodegenerative diseases. The present study investigated the role of inflammatory response resulting from Kv1.3 activation in WMI, as well as the effect of Kv1.3 blockade on microglia polarization after ICH. Methods: ICH was introduced in mice using autologous blood. The expression of Kv1.3 was determined using real-time quantitative polymerase chain reaction (RT-qPCR), immunoblot and immunostaining assays. Then, the effect of administration of 5-(4-Phenoxybutoxy) psoralen (PAP-1), a selectively pharmacological inhibitor of Kv1.3, on functional recovery was investigated using open field test (OFT) and basso mouse score (BMS). Next, the RT-qPCR, immunoblot and enzyme linked immunosorbent assay (ELISA) assays were performed to elucidate the changes of pro-inflammatory and anti-inflammatory factors around hematoma with PAP-1 application after ICH. Thereafter, the role of PAP-1 in regulating microglia polarization was examined through RT-qPCR, immunoblot and immunostaining assays. Results: After ICH, the expression of Kv1.3 was significantly increased in microglia around hematoma after ICH. The administration of PAP-1 markedly improved neurological outcomes through reducing the accumulation of pro-inflammatory cytokines and upregulating the deposition of anti-inflammatory and neurotrophic factors. The reason for this beneficial effect ascribes to facilitating microglia polarization into M2-like microglia. Conclusion: Kv1.3 blockade using PAP-1 obviously reduced the accumulation of pro-inflammatory cytokines and upregulated the deposition of anti-inflammatory and neurotrophic factors through facilitating microglia polarization into M2-like microglia. The present study provides evidence Kv1.3 blockade is suitable to mitigate WMI through facilitating microglia transformation into M2-like phenotype after ICH.
- Open Access
- 4 August 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 6160701
Dexpramipexole Attenuates White Matter Injury to Facilitate Locomotion and Motor Coordination Recovery via Reducing Ferroptosis after Intracerebral Hemorrhage
Deciphering the factors causing damage to white matter fiber bundles and exploring new strategies to alleviate white matter injury (WMI) is a promising treatment to improve neurological impairments after intracerebral hemorrhage (ICH). Ferroptosis usually occurs at perihematomal region and contributes to neuronal death due to reactive oxygen species (ROS) production. Dexpramipexole (DPX) easily crosses the blood brain barrier (BBB) and exerts antioxidative properties by reducing ROS production, while the role of DPX in ferroptosis after ICH remains elusive. Here, our results indicated that ferroptosis played a significant role in WMI resulting from iron and ROS accumulation around hematoma. Further evidence demonstrated that the administration of DPX decreased iron and ROS deposition to inhibit ferroptosis at perihematomal site. With the inhibition of ferroptosis, WMI was alleviated at perihematomal site, thereafter promoting locomotion and motor coordination recovery in mice after ICH. Subsequently, the results showcased that the expression of glutathione peroxidase 4 (GPX4) and ferroptosis suppressing protein 1 (FSP1) was upregulated with the administration of DPX. Collectively, the present study uncovers the underlying mechanism and elucidates the therapeutic effect of DPX on ICH, and even in other central nervous system (CNS) diseases with the presence of ferroptosis.
- 4 August 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 6160701
Open AccessDexpramipexole Attenuates White Matter Injury to Facilitate Locomotion and Motor Coordination Recovery via Reducing Ferroptosis after Intracerebral Hemorrhage
Deciphering the factors causing damage to white matter fiber bundles and exploring new strategies to alleviate white matter injury (WMI) is a promising treatment to improve neurological impairments after intracerebral hemorrhage (ICH). Ferroptosis usually occurs at perihematomal region and contributes to neuronal death due to reactive oxygen species (ROS) production. Dexpramipexole (DPX) easily crosses the blood brain barrier (BBB) and exerts antioxidative properties by reducing ROS production, while the role of DPX in ferroptosis after ICH remains elusive. Here, our results indicated that ferroptosis played a significant role in WMI resulting from iron and ROS accumulation around hematoma. Further evidence demonstrated that the administration of DPX decreased iron and ROS deposition to inhibit ferroptosis at perihematomal site. With the inhibition of ferroptosis, WMI was alleviated at perihematomal site, thereafter promoting locomotion and motor coordination recovery in mice after ICH. Subsequently, the results showcased that the expression of glutathione peroxidase 4 (GPX4) and ferroptosis suppressing protein 1 (FSP1) was upregulated with the administration of DPX. Collectively, the present study uncovers the underlying mechanism and elucidates the therapeutic effect of DPX on ICH, and even in other central nervous system (CNS) diseases with the presence of ferroptosis.